44.65 USD
↘ 0.29 (0.65%)AT CLOSE (11:59 AM EDT)
Exelixis Inc
EXELNASDAQ • USD
44.98
↗ 0.33 (0.74%)
POST MARKET (AS OF 06:19 PM EDT)
Post Market
AS OF 06:19 PM EDT
44.98
↗ 0.33 (0.74%)
Market: CLOSED
Open?$44.89
High?$45.82
Low?$44.61
Prev. Close?$44.94
Volume?2.1M
Avg. Volume?2.4M
VWAP?$45.02
Rel. Volume?0.87x
Bid / Ask
Bid?$44.60 × 500
Ask?$45.95 × 200
Spread?$1.35
Midpoint?$45.28
Valuation & Ratios
Market Cap?11.3B
Shares Out?254.0M
Float?251.4M
Float %?96.8%
P/E Ratio?14.49
P/B Ratio?5.25
EPS?$3.08
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.56Strong
Quick Ratio?3.50Strong
Cash Ratio?1.19Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?14.5CHEAP▾
P/B?5.25FAIR▾
P/S?4.89FAIR▾
P/FCF?13.0CHEAP▾
EV/EBITDA?11.8CHEAP▾
EV/Sales?4.68FAIR▾
Returns & Efficiency
ROE?36.2%STRONG▾
ROA?27.5%STRONG▾
Cash Flow & Enterprise
FCF?$875.8M
Enterprise Value?$10.9B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Employees
1.1K
Market Cap
11.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2000-04-11
Address
1851 HARBOR BAY PARKWAY
ALAMEDA, CA 94502
Phone: (650) 837-7000
ALAMEDA, CA 94502
Phone: (650) 837-7000